These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15888345)

  • 1. Transgenic mouse models for the prevention of breast cancer.
    Shen Q; Brown PH
    Mutat Res; 2005 Aug; 576(1-2):93-110. PubMed ID: 15888345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N; Katdare M
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary tumorigenesis and metastasis in transgenic mice.
    Webster MA; Muller WJ
    Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of transforming growth factor beta impact in breast development and cancer.
    Serra R; Crowley MR
    Endocr Relat Cancer; 2005 Dec; 12(4):749-60. PubMed ID: 16322320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic models of human cancer.
    Hinrichs SH; Fontes JD; Bills ND; Schneider PD
    Princess Takamatsu Symp; 1991; 22():259-74. PubMed ID: 1668887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary gland neoplasia: insights from transgenic mouse models.
    Siegel PM; Hardy WR; Muller WJ
    Bioessays; 2000 Jun; 22(6):554-63. PubMed ID: 10842309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling prostate cancer: a perspective on transgenic mouse models.
    Jeet V; Russell PJ; Khatri A
    Cancer Metastasis Rev; 2010 Mar; 29(1):123-42. PubMed ID: 20143131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer.
    Hanahan D; Wagner EF; Palmiter RD
    Genes Dev; 2007 Sep; 21(18):2258-70. PubMed ID: 17875663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mouse models of human breast cancer.
    Hutchinson JN; Muller WJ
    Oncogene; 2000 Dec; 19(53):6130-7. PubMed ID: 11156526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying drug resistance using genetically engineered mouse models for breast cancer.
    Rottenberg S; Pajic M; Jonkers J
    Methods Mol Biol; 2010; 596():33-45. PubMed ID: 19949919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rodent models for the study of etiology, prevention and treatment of breast cancer.
    Gould MN
    Semin Cancer Biol; 1995 Jun; 6(3):147-52. PubMed ID: 7495982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse models and breast cancer.
    Robinson A
    CMAJ; 1995 Oct; 153(8):1123-4. PubMed ID: 7553521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models for breast cancer.
    Hennighausen L
    Oncogene; 2000 Feb; 19(8):966-7. PubMed ID: 10713679
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre-clinical applications of transgenic mouse mammary cancer models.
    Kavanaugh CJ; Desai KV; Calvo A; Brown PH; Couldrey C; Lubet R; Green JE
    Transgenic Res; 2002 Dec; 11(6):617-33. PubMed ID: 12509137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice as an in vivo model of lymphomagenesis.
    Tarantul VZ
    Int Rev Cytol; 2004; 236():123-80. PubMed ID: 15261738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S; Munoz R; Kerbel RS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.
    Hursting SD; Nunez NP; Patel AC; Perkins SN; Lubet RA; Barrett JC
    Mutat Res; 2005 Aug; 576(1-2):80-92. PubMed ID: 15990122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.